Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Celltrion Discuss Biosimilar Drug Approval and the Patent Expiry of Top Selling BiologicsSMi Reports: Celltrion Healthcare Present Proven Case Study Insight at 8th Annual Biosimilars Industry Summit
By: SMi Group Highlights from the talk presented by HoUng Kim, Division Head for Strategy and Operations include: The Challenges of Gaining Approval: Attendees will leverage stringent standard criteria to overcome challenges in regulation as Celltrion draw from experience on the successful approval of two biosimilar drugs. Publishing Data: The presentation will cover ARD requirement on sensitivity analysis and discuss ways in which Celltrion demonstrated a similar response rate regardless of different statistical approaches. Future Landscape of Biosimialrs: Other speakers on the panel for 2017 will include Boehringer Ingelheim; Norwegian Medicines Agency; QuintilesIMS; Further details are available online at https://www.smi- Biosimilars & Biobetters 27th & 28th September 2017 Holiday Inn Kensington Forum, London UK --end – Contact Information: For media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk For all other enquires contact the team on Tel: +44 (0)20 7827 6000 or email events@smi-online.co.uk About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|